Korean Journal of Biological Psychiatry (생물정신의학)

The Korean Society of Biological Psychiatry (대한생물정신의학회)
권호 표지

Practical Considerations in Anesthesia for Electroconvulsive Therapy

전기경련치료의 마취를 위한 실제적 문제들

  • Youn, Tak (Department of Psychiatry, Dongguk University International Hospital) ;
  • Kim, Yong Sik (Department of Psychiatry, Dongguk University International Hospital) ;
  • Lee, Nam Young (Department of Psychiatry, Dongguk University International Hospital) ;
  • Kim, Se Hyun (Department of Psychiatry, Dongguk University International Hospital) ;
  • Choi, Jun Gwon (Electroconvulsive Therapy Center, Dongguk University International Hospital) ;
  • Lee, Jeoung Hyuk (Department of Anesthesiology and Pain Medicine, Dongguk University International Hospital) ;
  • Chung, In Won (Department of Psychiatry, Dongguk University International Hospital)
  • 윤탁 (동국대학교 일산병원 정신건강의학과) ;
  • 김용식 (동국대학교 일산병원 정신건강의학과) ;
  • 이남영 (동국대학교 일산병원 정신건강의학과) ;
  • 김세현 (동국대학교 일산병원 정신건강의학과) ;
  • 최준권 (동국대학교 일산병원 전기경련치료센터) ;
  • 이정혁 (동국대학교 일산병원 마취통증의학과) ;
  • 정인원 (동국대학교 일산병원 정신건강의학과)
  • Received : 2017.06.07
  • Accepted : 2017.07.17
  • Published : 2017.08.31
Download PDF
⟨ Previous Next ⟩

Abstract

Electroconvulsive therapy (ECT) has been recognized effective as primary or secondary treatments for major psychiatric disorders including depression and schizophrenia, as well as psychiatric emergency such as suicide, food refusal and catatonia, and so on. Medicines used in anesthetic induction for ECT, cause various reactions in autonomous, hemodynamic, and neuromuscular systems. The anesthetics also affect the duration, threshold, and intensity of seizures evoked with electric stimuli, and thus modify the seizure quality in ECT. Individual characteristics of age, sex, weight, comorbid physical disorders, and medications should also be considered for optimal clinical response after ECT. When preparing for anesthesia, adequate anesthetic agents and muscle relaxants, and rapid recovery should be carefully considered. We conducted a case-series study to address practical issues that are frequently encountered during ECT anesthesia with reviews of updated journals in order to provide practical helps to clinicians who are preparing ECT for their patients.

Keywords

References

  1. Bailine S, Fink M, Knapp R, Petrides G, Husain MM, Rasmussen K, et al. Electroconvulsive therapy is equally effective in unipolar and bipolar depression. Acta Psychiatr Scand 2010;121:431-436.
  2. Nobler MS, Sackeim HA. Electroconvulsive therapy. In: Henn F, Sartorius N, Helmchen H, Lauter H, editors. Contemporary psychiatry. Berlin: Springer-Verlag Berlin Heidelberg;2001. p.1795-1803.
  3. Thomann PA, Wolf RC, Nolte HM, Hirjak D, Hofer S, Seidl U, et al. Neuromodulation in response to electroconvulsive therapy in schizophrenia and major depression. Brain Stimul 2017;10:637-644. https://doi.org/10.1016/j.brs.2017.01.578
  4. Saito S. Anesthesia management for electroconvulsive therapy: hemodynamic and respiratory management. J Anesth 2005;19:142-149. https://doi.org/10.1007/s00540-004-0288-7
  5. Youn T, Kang UG, Kim YS, Chung IW. Recent trends for optimization of electroconvulsive therapy. J Korean Neuropsychiatr Assoc 2016;55:12-24. https://doi.org/10.4306/jknpa.2016.55.1.12
  6. Demoto Y. Comprehensive monitoring during procedures under reasonable anesthetic control. In: Saito S, editor. Anesthesia management for electroconvulsive therapy: practical techniques and physiological background. Tokyo: Springer Japan;2016. p.17-47.
  7. Jeong JH, Youn T, Kim YS. History of electroconvulsive therapy. In: Kim YS, editor. Electroconvulsive therapy. Seoul: Seoul National University Press; In press.
  8. Holmberg G, Thesleff S. Succinyl-choline-iodide as a muscular relaxant in electroshock therapy. Am J Psychiatry 1952;108:842-846. https://doi.org/10.1176/ajp.108.11.842
  9. Chung IW, Choi JK. Anesthesia for electroconvulsive therapy. In: Kim YS, editor. Electroconvulsive therapy. Seoul; Seoul National University Press; In press.
  10. Coffey CE, Kellner C. Electroconvulsive therapy. In: Coffey CE, Cummings JL, editors. The American Psychiatric Press textbook of geriatric neuropsychiatry. Washington, DC: American Psychiatric Press;2000. p.829-859.
  11. Kim EY, Youn T, Kim YS. Electroconvulsive therapy in special population. In: Kim YS, editor. Electroconvulsive therapy. Seoul: Seoul National University Press; In press.
  12. American Psychiatric Association, Committee on Electroconvulsive Therapy. The practice of electroconvulsive therapy : recommendations for treatment, training, and privileging: a task force report of the American Psychiatric Association. 2nd ed. Washington, DC: American Psychiatric Association;2001.
  13. American Society of Anesthesiologists Committee. Practice guidelines for preoperative fasting and the use of pharmacologic agents to reduce the risk of pulmonary aspiration: application to healthy patients undergoing elective procedures: an updated report by the American Society of Anesthesiologists Committee on Standards and Practice Parameters. Anesthesiology 2011;114:495-511. https://doi.org/10.1097/ALN.0b013e3181fcbfd9
  14. Bryson EO, Kellner CH. Airway and respiratoty management during electroconvulsive therapy (ECT). In: Saito S, editor. Anesthesia management for electroconvulsive therapy: practical techniques and physiological background. Tokyo: Springer;2016. p.66.
  15. Jaffe R, Dubin W, Shoyer B, Roemer R, Sharon D, Lipschutz L. Outpatient electroconvulsive therapy: efficacy and safety. Convuls Ther 1990;6:231-238.
  16. Kramer BA. Outpatient electroconvulsive therapy: a cost-saving alternative. Hosp Community Psychiatry 1990;41:361-363.
  17. Lee JE, Park SJ, Lim JG, Yang HS. Ambulatory anesthetic care for electroconvulsive therapy (ECT) in psychiatric patients. Korean J Anesthesiol 2002;43:520-524. https://doi.org/10.4097/kjae.2002.43.4.520
  18. Pal R, Pal VS. Anesthesia for electroconvulsive therapy: a noble approach. Int J Med Res Health Sci 2015;4:890-895. https://doi.org/10.5958/2319-5886.2015.00179.4
  19. Brown NI, Mack PF, Mitera DM, Dhar P. Use of the ProSeal laryngeal mask airway in a pregnant patient with a difficult airway during electroconvulsive therapy. Br J Anaesth 2003;91:752-754. https://doi.org/10.1093/bja/aeg227
  20. Haeck M, Gillmann B, Janouschek H, Grozinger M. Electroconvulsive therapy can benefit from controlled hyperventilation using a laryngeal mask. Eur Arch Psychiatry Clin Neurosci 2011;261 Suppl 2: S172-S176. https://doi.org/10.1007/s00406-011-0240-4
  21. Azuma H, Fujita A, Sato K, Arahata K, Otsuki K, Hori M, et al. Postictal suppression correlates with therapeutic efficacy for depression in bilateral sine and pulse wave electroconvulsive therapy. Psychiatry Clin Neurosci 2007;61:168-173. https://doi.org/10.1111/j.1440-1819.2007.01632.x
  22. Nobler MS, Sackeim HA, Solomou M, Luber B, Devanand DP, Prudic J. EEG manifestations during ECT: effects of electrode placement and stimulus intensity. Biol Psychiatry 1993;34:321-330. https://doi.org/10.1016/0006-3223(93)90089-V
  23. McCall WV, Robinette GD, Hardesty D. Relationship of seizure morphology to the convulsive threshold. Convuls Ther 1996;12:147-151.
  24. Bailine SH, Safferman A, Vital-Herne J, Bernstein S. Flumazenil reversal of benzodiazepine-induced sedation for a patient with severe pre-ECT anxiety. Convuls Ther 1994;10:65-68.
  25. Krystal AD, Watts BV, Weiner RD, Moore S, Steffens DC, Lindahl V. The use of flumazenil in the anxious and benzodiazepine-dependent ECT patient. J ECT 1998;14:5-14.
  26. Reves JG, Glass P, Lubarsky DA, McEvoy MD, Ruiz RM. Intravenous anesthetics. In: Miller RD, editor. Miller's anesthesia. Philadelphia, PA: Churchill Livingstone/Elsevier;2010. p.719-771.
  27. Kurdi MS, Theerth KA, Deva RS. Ketamine: current applications in anesthesia, pain, and critical care. Anesth Essays Res 2014;8:283-290. https://doi.org/10.4103/0259-1162.143110
  28. Shettar SM, Grunhaus L, Pande AC, Tandon RC, Kronfol ZA, Haskett RF. Protective effects of intramuscular glycopyrrolate on cardiac conduction during ECT. Convuls Ther 1989;5:349-352.
  29. Knos GB, Sung YF, Cooper RC, Stoudemire A. Electroconvulsive therapy--induced hemodynamic changes unmask unsuspected coronary artery disease. J Clin Anesth 1990;2:37-41. https://doi.org/10.1016/0952-8180(90)90048-8
  30. Uppal V, Dourish J, Macfarlane A. Anaesthesia for electroconvulsive therapy. Contin Educ Anaesth Crit Care Pain 2010;10:192-196. https://doi.org/10.1093/bjaceaccp/mkq039
  31. Kramer BA, Allen RE, Friedman B. Atropine and glycopyrrolate as ECT preanesthesia. J Clin Psychiatry 1986;47:199-200.
  32. Kelway B, Simpson KH, Smith RJ, Halsall PJ. Effects of atropine and glycopyrrolate on cognitive function following anaesthesia and electroconvulsive therapy (ECT). Int Clin Psychopharmacol 1986;1: 296-302. https://doi.org/10.1097/00004850-198610000-00003
  33. Sommer BR, Satlin A, Friedman L, Cole JO. Glycopyrrolate versus atropine in post-ECT amnesia in the elderly. J Geriatr Psychiatry Neurol 1989;2:18-21.
  34. MacPherson RD, Lawford J, Simpson B, Mahon M, Scott D, Loo C. Low dose lignocaine added to propofol does not attenuate the response to electroconvulsive therapy. J Affect Disord 2010;126:330-333. https://doi.org/10.1016/j.jad.2010.02.134
  35. Rasmussen KG, Ritter MJ. Anesthetic-induced pain on injection in electroconvulsive therapy: review of the literature and suggestions for prevention. J ECT 2014;30:203-209. https://doi.org/10.1097/YCT.0000000000000088
  36. Eriksson M. Prilocaine reduces injection pain caused by propofol. Acta Anaesthesiol Scand 1995;39:210-213. https://doi.org/10.1111/j.1399-6576.1995.tb04045.x
  37. Fu W, Stool LA, White PF, Husain MM. Acute hemodynamic responses to electroconvulsive therapy are not related to the duration of seizure activity. J Clin Anesth 1997;9:653-657. https://doi.org/10.1016/S0952-8180(97)00191-8
  38. Gajraj NM, Nathanson MH. Preventing pain during injection of propofol: the optimal dose of lidocaine. J Clin Anesth 1996;8:575-577. https://doi.org/10.1016/S0952-8180(96)00133-X
  39. Helbo-Hansen S, Westergaard V, Krogh BL, Svendsen HP. The reduction of pain on injection of propofol: the effect of addition of lignocaine. Acta Anaesthesiol Scand 1988;32:502-504. https://doi.org/10.1111/j.1399-6576.1988.tb02774.x
  40. King SY, Davis FM, Wells JE, Murchison DJ, Pryor PJ. Lidocaine for the prevention of pain due to injection of propofol. Anesth Analg 1992;74:246-249. https://doi.org/10.1213/00000539-199202000-00013
  41. Lee SH, Bae HB, Jeong CY, Chung SS, Yoo KY. The effect of lidocaine on propofol-induced hemodynamic changes during induction of anesthesia in elderly patients. Korean J Anesthesiol 2005;48:614-618. https://doi.org/10.4097/kjae.2005.48.6.614
  42. Heo JS, Kim GH, Lee SM. Anesthesia for caffeine augmentation in electroconvulsive therapy: a case report. Korean J Anesthesiol 2006; 50:236-239. https://doi.org/10.4097/kjae.2006.50.2.236
  43. Watts BV, Groft A, Bagian JP, Mills PD. An examination of mortality and other adverse events related to electroconvulsive therapy using a national adverse event report system. J ECT 2011;27:105-108. https://doi.org/10.1097/YCT.0b013e3181f6d17f
  44. American Society of Anesthesiologists Task Force on Perioperative Management of patients with obstructive sleep apnea. Practice guidelines for the perioperative management of patients with obstructive sleep apnea: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Management of patients with obstructive sleep apnea. Anesthesiology 2014;120:268-286. https://doi.org/10.1097/ALN.0000000000000053
  45. Gupta MA, Simpson FC. Obstructive sleep apnea and psychiatric disorders: a systematic review. J Clin Sleep Med 2015;11:165-175.
  46. Verduzco LA, Lemmens HJ. What is the best way to induce general anesthesia in obese patients? In: Leykin Y, Brodsky J, editors. Controversies in the Anesthetic Management of the Obese Surgical Patient. Milano: Springer;2013. p.157-168.
  47. Langeron O, Masso E, Huraux C, Guggiari M, Bianchi A, Coriat P, et al. Prediction of difficult mask ventilation. Anesthesiology 2000; 92:1229-1236. https://doi.org/10.1097/00000542-200005000-00009
  48. Surve R, Bansal S, Sriganesh K, Subbakrishna DK, Thirthalli J, Umamaheswara Rao GS. Incidence and risk factors for oxygen desaturation during recovery from modified electroconvulsive therapy: a prospective observational study. J Anaesthesiol Clin Pharmacol 2015;31:99-103. https://doi.org/10.4103/0970-9185.150555
  49. World Health Organization. "BMI Classification". Global Database on Body Mass Index;2012.
  50. Kadar AG, Ing CH, White PF, Wakefield CA, Kramer BA, Clark K. Anesthesia for electroconvulsive therapy in obese patients. Anesth Analg 2002;94:360-361.
  51. Bergsholm P, Gran L, Bleie H. Seizure duration in unilateral electroconvulsive therapy. The effect of hypocapnia induced by hyperventilation and the effect of ventilation with oxygen. Acta Psychiatr Scand 1984;69:121-128. https://doi.org/10.1111/j.1600-0447.1984.tb02475.x
  52. Datto C, Rai AK, Ilivicky HJ, Caroff SN. Augmentation of seizure induction in electroconvulsive therapy: a clinical reappraisal. J ECT 2002;18:118-125. https://doi.org/10.1097/00124509-200209000-00002
  53. Pande AC, Shea J, Shettar S, Grunhaus LJ, Haskett RF. Effect of hyperventilation on seizure length during electroconvulsive therapy. Biol Psychiatry 1990;27:799-801. https://doi.org/10.1016/0006-3223(90)90597-U
  54. Sartorius A, Munoz-Canales EM, Krumm B, Krier A, Andres FJ, Bender HJ, et al. ECT anesthesia: the lighter the better? Pharmacopsychiatry 2006;39:201-204. https://doi.org/10.1055/s-2006-950395
  55. Lihua P, Su M, Ke W, Ziemann-Gimmel P. Different regimens of intravenous sedatives or hypnotics for electroconvulsive therapy (ECT) in adult patients with depression. Cochrane Database Syst Rev 2014 Apr 11 [Epub]. https://doi.org/10.1002/14651858.CD009763.pub2.
  56. Avramov MN, Husain MM, White PF. The comparative effects of methohexital, propofol, and etomidate for electroconvulsive therapy. Anesth Analg 1995;81:596-602.
  57. Jun GW, Yang HS, Lee YK, Seo HJ. Anesthetic efficacy of etomidate, propofol and thiopental sodium during electroconvulsive therapy. Anesth Pain Med 2011;6:32-36.
  58. Lee IH, Kong MH. The Comparison of the effects of propofol and etomidate on seizure duration and hemodynamic responses during ECT. Korean J Anesthesiol 2000;39:29-36. https://doi.org/10.4097/kjae.2000.39.1.29
  59. Rasmussen KG. Propofol for ECT anesthesia a review of the literature. J ECT 2014;30:210-215. https://doi.org/10.1097/YCT.0000000000000093
  60. Hooten WM, Rasmussen KG Jr. Effects of general anesthetic agents in adults receiving electroconvulsive therapy: a systematic review. J ECT 2008;24:208-223. https://doi.org/10.1097/YCT.0b013e31815bfe2a
  61. Eranti SV, Mogg AJ, Pluck GC, Landau S, McLoughlin DM. Methohexitone, propofol and etomidate in electroconvulsive therapy for depression: a naturalistic comparison study. J Affect Disord 2009; 113:165-171. https://doi.org/10.1016/j.jad.2008.03.004
  62. Mitchell P, Torda T, Hickie I, Burke C. Propofol as an anaesthetic agent for ECT: effect on outcome and length of course. Aust N Z J Psychiatry 1991;25:255-261. https://doi.org/10.3109/00048679109077742
  63. Bauer J, Hageman I, Dam H, Baez A, Bolwig T, Roed J, et al. Comparison of propofol and thiopental as anesthetic agents for electroconvulsive therapy: a randomized, blinded comparison of seizure duration, stimulus charge, clinical effect, and cognitive side effects. J ECT 2009;25:85-90. https://doi.org/10.1097/YCT.0b013e31818a0203
  64. Kellner CH, Bryson EO. Electroconvulsive therapy anesthesia technique: minimalist versus maximally managed. J ECT 2013;29:153-155. https://doi.org/10.1097/YCT.0b013e31827a7aef
  65. Kim EJ, Kim SH, Hyun YJ, Noh YK, Jung HS, Han SY, et al. Clinical and psychological characteristics of propofol abusers in Korea: a survey of propofol abuse in 38, non-healthcare professionals. Korean J Anesthesiol 2015;68:586-593. https://doi.org/10.4097/kjae.2015.68.6.586
  66. Kim JH, Byun H, Kim JH. Abuse potential of propofol used for sedation in gastric endoscopy and its correlation with subject characteristics. Korean J Anesthesiol 2013;65:403-409. https://doi.org/10.4097/kjae.2013.65.5.403
  67. Earley PH, Finver T. Addiction to propofol: a study of 22 treatment cases. J Addict Med 2013;7:169-176. https://doi.org/10.1097/ADM.0b013e3182872901
  68. Trzepacz PT, Weniger FC, Greenhouse J. Etomidate anesthesia increases seizure duration during ECT. A retrospective study. Gen Hosp Psychiatry 1993;15:115-120. https://doi.org/10.1016/0163-8343(93)90107-Y
  69. Tan HL, Lee CY. Comparison between the effects of propofol and etomidate on motor and electroencephalogram seizure duration during electroconvulsive therapy. Anaesth Intensive Care 2009;37:807-814.
  70. Singh PM, Arora S, Borle A, Varma P, Trikha A, Goudra BG. Evaluation of etomidate for seizure duration in electroconvulsive therapy: a systematic review and meta-analysis. J ECT 2015;31:213-225. https://doi.org/10.1097/YCT.0000000000000212
  71. Ball C, Westhorpe R. Intravenous induction agents: etomidate. Anaesth Intensive Care 2002;30:405.
  72. Lebowitz P. Etomidate is still a valid anesthetic for electroconvulsive therapy. J ECT 2014;30:261-262. https://doi.org/10.1097/YCT.0000000000000157
  73. Youn T, Chung IW, Kim YS. Stimulation dosage and methods. In: Kim YS, editor. Electroconvulsive therapy. Seoul: Seoul National University Press; In press.
  74. Yi J, Torres J, Azner Y, Vaidya P, Schiavi A, Reti IM. Flumazenil pretreatment in benzodiazepine-free patients: a novel method for managing declining ECT seizure quality. J ECT 2012;28:185-189. https://doi.org/10.1097/YCT.0b013e3182507752
  75. Park HS, Lee JH, Lee KN, Moon JI. Comparision of propofol and thiopental for electroconvulsive therapy: effects on hemodynamic changes and intraocular pressure. Korean J Anesthesiol 1996;30:305-310. https://doi.org/10.4097/kjae.1996.30.3.305
  76. Kang CK, Shin OY, Kim KS, Choi YK, Kwon MI. Comparision of propofol and thiopental sodium as anesthetic induction agents for electroconvulsive therapy. Korean J Anesthesiol 1996;31:184-189. https://doi.org/10.4097/kjae.1996.31.2.184
  77. Choe YK, Lee SR, Lee KM, Cheong SH, Kim YJ, Shin CM, et al. Correlation between pre-ictal bispectral index and seizure duration during electroconvulsive therapy under thiopental anesthesia. Korean J Anesthesiol 2003;45:693-696. https://doi.org/10.4097/kjae.2003.45.6.693
  78. Thimmaiah R, Thirthalli J, Ramesh VJ, Radhakrishnan MC, Muralidharan K, Mahadevaiah M, et al. Effect of a course of electroconvulsive therapy on interictal bispectral index values: a prospective study. J ECT 2012;28:20-23. https://doi.org/10.1097/YCT.0b013e318235b658
  79. Litt L, Li D. Awareness without recall during anesthesia for electroconvulsive therapy. Anesthesiology 2007;106:871-872. https://doi.org/10.1097/01.anes.0000264771.64168.63
  80. Titch JF, Vacchiano C. Pre-ictal bispectral index values; are they accurate? Br J Anaesth 2015;114:529-530. https://doi.org/10.1093/bja/aev019
  81. Bryson EO, Briggs MC, Pasculli RM, Popeo DM, Kellner CH. Depth of anesthesia appropriate for electroconvulsive therapy: the lash reflex need not be abolished. J ECT 2014;30:e40. https://doi.org/10.1097/YCT.0000000000000098
  82. Gajwani P, Muzina D, Gao K, Calabrese JR. Awareness under anesthesia during electroconvulsive therapy treatment. J ECT 2006;22: 158-159. https://doi.org/10.1097/00124509-200606000-00018
  83. Rule E, Reddy S. Awareness under general anaesthesia. Br J Hosp Med (Lond) 2014;75:573-577. https://doi.org/10.12968/hmed.2014.75.10.573
  84. Myles PS, Leslie K, McNeil J, Forbes A, Chan MT. Bispectral index monitoring to prevent awareness during anaesthesia: the B-Aware randomised controlled trial. Lancet 2004;363:1757-1763. https://doi.org/10.1016/S0140-6736(04)16300-9
  85. Pandit JJ, Andrade J, Bogod DG, Hitchman JM, Jonker WR, Lucas N, et al. The 5th National Audit Project (NAP5) on accidental awareness during general anaesthesia: summary of main findings and risk factors. Anaesthesia 2014;69:1089-1101. https://doi.org/10.1111/anae.12826
  86. Sebel PS, Bowdle TA, Ghoneim MM, Rampil IJ, Padilla RE, Gan TJ, et al. The incidence of awareness during anesthesia: a multicenter United States study. Anesth Analg 2004;99:833-839. https://doi.org/10.1213/01.ANE.0000130261.90896.6C
  87. Ghoneim MM, Block RI, Haffarnan M, Mathews MJ. Awareness during anesthesia: risk factors, causes and sequelae: a review of reported cases in the literature. Anesth Analg 2009;108:527-535. https://doi.org/10.1213/ane.0b013e318193c634
  88. Punjasawadwong Y, Boonjeungmonkol N, Phongchiewboon A. Bispectral index for improving anaesthetic delivery and postoperative recovery. Cochrane Database Syst Rev 2007 Oct 17 [Epub]. https://doi.org/10.1002/14651858.CD003843.pub2.
  89. Avidan MS, Zhang L, Burnside BA, Finkel KJ, Searleman AC, Selvidge JA, et al. Anesthesia awareness and the bispectral index. N Engl J Med 2008;358:1097-1108. https://doi.org/10.1056/NEJMoa0707361
  90. Brice DD, Hetherington RR, Utting JE. A simple study of awareness and dreaming during anaesthesia. Br J Anaesth 1970;42:535-542. https://doi.org/10.1093/bja/42.6.535
  91. Kempen PM. Electroconvulsive therapy: compassion in care and risk-benefits of discomfort. Anesthesiology 2007;107:857; author reply 857-858. https://doi.org/10.1097/01.anes.0000287343.24019.f4
  92. Peterchev AV, Rosa MA, Deng ZD, Prudic J, Lisanby SH. Electroconvulsive therapy stimulus parameters: rethinking dosage. J ECT 2010;26:159-174. https://doi.org/10.1097/YCT.0b013e3181e48165
  93. Nishikawa K, Yanmakage M. Reconsideration of augmentation strategies in electroconvulsive therapy: effects of the concurrent use of a reduced dose of propofol with divided supplemental remifentanil and moderate hyperventilation on electroconvulsive therapy-induced seizure production and adverse events. Open J Anesthesiol 2015;5:219-226. https://doi.org/10.4236/ojanes.2015.510040
  94. Sawayama E, Takahashi M, Inoue A, Nakajima K, Kano A, Sawayama T, et al. Moderate hyperventilation prolongs electroencephalogram seizure duration of the first electroconvulsive therapy. J ECT 2008;24:195-198. https://doi.org/10.1097/YCT.0b013e3181620815
  95. Chen ST. Remifentanil: a review of its use in electroconvulsive therapy. J ECT 2011;27:323-327. https://doi.org/10.1097/YCT.0b013e31821072d2
  96. Nishikawa K, Higuchi M, Kawagishi T, Shimodate Y, Yamakage M. Effect of divided supplementation of remifentanil on seizure duration and hemodynamic responses during electroconvulsive therapy under propofol anesthesia. J Anesth 2011;25:29-33. https://doi.org/10.1007/s00540-010-1049-4
  97. Abdallah CG, Fasula M, Kelmendi B, Sanacora G, Ostroff R. Rapid antidepressant effect of ketamine in the electroconvulsive therapy setting. J ECT 2012;28:157-161. https://doi.org/10.1097/YCT.0b013e31824f8296
  98. Weiner RD. The psychiatric use of electrically induced seizures. Am J Psychiatry 1979;136:1507-1517. https://doi.org/10.1176/ajp.136.12.1507
  99. Scott AI. Hyperventilation and seizure quality. J ECT 2014;30:e39.
  100. Bergsholm P, Bleie H, Gran L, d'Elia G. Cardiovascular response and seizure duration as determined by electroencephalography during unilateral electroconvulsive therapy. Acta Psychiatr Scand 1993;88:25-28. https://doi.org/10.1111/j.1600-0447.1993.tb03409.x
  101. Galvez V, Loo CK. Clinical applicability of monitoring the time interval between anesthesia and electroconvulsive therapy. J ECT 2017;33:4-6. https://doi.org/10.1097/YCT.0000000000000384
  102. Beale MD, Kellner CH, Lemert R, Pritchett JT, Bernstein HJ, Burns CM, et al. Skeletal muscle relaxation in patients undergoing electroconvulsive therapy. Anesthesiology 1994;80:957.
  103. Recart A, Rawal S, White PF, Byerly S, Thornton L. The effect of remifentanil on seizure duration and acute hemodynamic responses to electroconvulsive therapy. Anesth Analg 2003;96:1047-1050.
  104. van Zijl DH, Gordon PC, James MF. The comparative effects of remifentanil or magnesium sulfate versus placebo on attenuating the hemodynamic responses after electroconvulsive therapy. Anesth Analg 2005;101:1651-1655.
  105. Rasmussen KG, Imig MW, Varghese R. Remifentanil/Thiopental combination and seizure length in electroconvulsive therapy. J ECT 2009;25:31-33. https://doi.org/10.1097/YCT.0b013e3181788270
  106. Dinwiddie SH, Glick DB, Goldman MB. The effect of propofolremifentanil anesthesia on selected seizure quality indices in electroconvulsive therapy. Brain Stimul 2012;5:402-407. https://doi.org/10.1016/j.brs.2011.06.008
  107. Kadoi Y, Saito S. Effects of adding remifentanil to propofol anesthesia on systemic hemodynamics, cardiac output, and middle cerebral artery flow velocity during electroconvulsive therapy: a pilot study. J ECT 2015;31:98-100. https://doi.org/10.1097/YCT.0000000000000202
  108. Sedighinejad A, Nabi BN, Haghighi M, Farzam A, Sayyah Z, Kabiri M, et al. Electroconvulsive therapy-related cognitive impairment and choice of anesthesia: the tipping point. J ECT 2015;31:101-104. https://doi.org/10.1097/YCT.0000000000000187
  109. MacPherson RD. Which anesthetic agents for ambulatory electroconvulsive therapy? Curr Opin Anaesthesiol 2015;28:656-661.
  110. Takekita Y, Suwa T, Sunada N, Kawashima H, Fabbri C, Kato M, et al. Remifentanil in electroconvulsive therapy: a systematic review and meta-analysis of randomized controlled trials. Eur Arch Psychiatry Clin Neurosci 2016;266:703-717. https://doi.org/10.1007/s00406-016-0670-0
  111. Loo CK, Galvez Galve V. Ketamine and electroconvulsive therapy. In: Mathew SJ, Zarate, Jr. CA, editors. Ketamine for treatment-resistant depression: the first decade of progress. Cham: Springer;2016. p.123-135.
  112. Galvez V, McGuirk L, Loo CK. The use of ketamine in ECT anaesthesia: a systematic review and critical commentary on efficacy, cognitive, safety and seizure outcomes. World J Biol Psychiatry 2017;18:424-444. https://doi.org/10.1080/15622975.2016.1252464
  113. Lunn RJ, Savageau MM, Beatty WW, Gerst JW, Staton RD, Brumback RA. Anesthetics and electroconvulsive therapy seizure duration: implications for therapy from a rat model. Biol Psychiatry 1981;16:1163-1175.
  114. Krystal AD, Weiner RD, Dean MD, Lindahl VH, Tramontozzi LA 3rd, Falcone G, et al. Comparison of seizure duration, ictal EEG, and cognitive effects of ketamine and methohexital anesthesia with ECT. J Neuropsychiatry Clin Neurosci 2003;15:27-34. https://doi.org/10.1176/jnp.15.1.27
  115. Kranaster L, Kammerer-Ciernioch J, Hoyer C, Sartorius A. Clinically favourable effects of ketamine as an anaesthetic for electroconvulsive therapy: a retrospective study. Eur Arch Psychiatry Clin Neurosci 2011;261:575-582. https://doi.org/10.1007/s00406-011-0205-7
  116. Loo CK, Katalinic N, Garfield JB, Sainsbury K, Hadzi-Pavlovic D, Mac-Pherson R. Neuropsychological and mood effects of ketamine in electroconvulsive therapy: a randomised controlled trial. J Affect Disord 2012;142:233-240. https://doi.org/10.1016/j.jad.2012.04.032
  117. Jarventausta K, Chrapek W, Kampman O, Tuohimaa K, Bjorkqvist M, Hakkinen H, et al. Effects of S-ketamine as an anesthetic adjuvant to propofol on treatment response to electroconvulsive therapy in treatment-resistant depression: a randomized pilot study. J ECT 2013;29:158-161. https://doi.org/10.1097/YCT.0b013e318283b7e9
  118. Rasmussen KG. Psychiatric side effects of ketamine in hospitalized medical patients administered subanesthetic doses for pain control. Acta Neuropsychiatr 2014;26:230-233. https://doi.org/10.1017/neu.2013.61
  119. Ghasemi M, Kazemi MH, Yoosefi A, Ghasemi A, Paragomi P, Amini H, et al. Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder. Psychiatry Res 2014;215: 355-361. https://doi.org/10.1016/j.psychres.2013.12.008
  120. Okamoto N, Nakai T, Sakamoto K, Nagafusa Y, Higuchi T, Nishikawa T. Rapid antidepressant effect of ketamine anesthesia during electroconvulsive therapy of treatment-resistant depression: comparing ketamine and propofol anesthesia. J ECT 2010;26:223-227. https://doi.org/10.1097/YCT.0b013e3181c3b0aa
  121. Erdogan Kayhan G, Yucel A, Colak YZ, Ozgul U, Yologlu S, Karlidag R, et al. Ketofol (mixture of ketamine and propofol) administration in electroconvulsive therapy. Anaesth Intensive Care 2012;40: 305-310.
  122. Wang X, Chen Y, Zhou X, Liu F, Zhang T, Zhang C. Effects of propofol and ketamine as combined anesthesia for electroconvulsive therapy in patients with depressive disorder. J ECT 2012;28:128-132. https://doi.org/10.1097/YCT.0b013e31824d1d02
  123. McGirr A, Berlim MT, Bond DJ, Neufeld NH, Chan PY, Yatham LN, et al. A systematic review and meta-analysis of randomized controlled trials of adjunctive ketamine in electroconvulsive therapy: efficacy and tolerability. J Psychiatr Res 2015;62:23-30. https://doi.org/10.1016/j.jpsychires.2015.01.003
  124. Angst J, Angst K, Baruffol I, Meinherz-Surbeck R. ECT-induced and drug-induced hypomania. Convuls Ther 1992;8:179-185.
  125. Fernie G, Currie J, Perrin JS, Stewart CA, Anderson V, Bennett DM, et al. Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial. Br J Psychiatry 2017; 210:422-428. https://doi.org/10.1192/bjp.bp.116.189134
  126. Anderson IM, Blamire A, Branton T, Clark R, Downey D, Dunn G, et al. Ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT): a multicentre, double-blind, randomised, parallelgroup, superiority trial. Lancet Psychiatry 2017;4:365-377. https://doi.org/10.1016/S2215-0366(17)30077-9
  127. Enns M, Peeling J, Sutherland GR. Hippocampal neurons are damaged by caffeine-augmented electroshock seizures. Biol Psychiatry 1996;40:642-647. https://doi.org/10.1016/0006-3223(95)00450-5
  128. Li EH, Bryson EO, Kellner CH. Muscle relaxation with succinylcholine in electroconvulsive therapy. Anesth Analg 2016;123:1329.
  129. Mirzakhani H, Welch CA, Eikermann M, Nozari A. Neuromuscular blocking agents for electroconvulsive therapy: a systematic review. Acta Anaesthesiol Scand 2012;56:3-16. https://doi.org/10.1111/j.1399-6576.2011.02520.x
  130. Adnet F, Le Moyec L, Smith CE, Galinski M, Jabre P, Lapostolle F. Stability of succinylcholine solutions stored at room temperature studied by nuclear magnetic resonance spectroscopy. Emerg Med J 2007;24:168-169. https://doi.org/10.1136/emj.2006.041053
  131. Kopman AF, Zhaku B, Lai KS. The "intubating dose" of succinylcholine: the effect of decreasing doses on recovery time. Anesthesiology 2003;99:1050-1054. https://doi.org/10.1097/00000542-200311000-00007
  132. Nott MR, Watts JS. A fractured hip during electro-convulsive therapy. Eur J Anaesthesiol 1999;16:265-267. https://doi.org/10.1097/00003643-199904000-00011
  133. Sarpel Y, Togrul E, Herdem M, Tan I, Baytok G. Central acetabular fracture-dislocation following electroconvulsive therapy: report of two similar cases. J Trauma 1996;41:342-344. https://doi.org/10.1097/00005373-199608000-00025
  134. Durant NN, Katz RL. Suxamethonium. Br J Anaesth 1982;54:195-208. https://doi.org/10.1093/bja/54.2.195
  135. Kadoi Y. Selection of anesthetics and muscle relaxants for electroconvulsive therapy. In: Saito S, editor. Anesthesia management for electroconvulsive therapy: practical techniques and physiological background. Tokyo: Springer;2016. p.49-65.
  136. Sato M. Postprocedural assessments and considerations. In: Saito S, editor. Anesthesia management for electroconvulsive therapy: practical techniques and physiological background. Tokyo: Springer; 2016. p.99-124.
  137. Ammundsen HB, Sorensen MK, Gatke MR. Succinylcholine resistance. Br J Anaesth 2015;115:818-821. https://doi.org/10.1093/bja/aev228
  138. Ok SH, Woo MK, Kim CG, Hwang I, Sohn JT. Delayed recovery from paralysis by succinylcholine in patient with preoperatively unrecognized and inherited pseudocholinesterase deficiency. Korean J Anesthesiol 2013;65(6 Suppl):S19-S20. https://doi.org/10.4097/kjae.2013.65.6S.S19
  139. Lee JH, Hahn MH, Chung SH, Choi YS, Chang JY, Bae CW, et al. Statistic observation of marriages, births, and children in multicultural families and policy perspectives in Korea. Korean J Perinatol 2012;23:76-86.
  140. Shin OY, Kang CH, Kim KS. The effect of the intravenous esmolol on blood pressure and heart rate during electroconvulsive therapy. Korean J Anesthesiol 1997;33:1054-1060. https://doi.org/10.4097/kjae.1997.33.6.1054
  141. Ham SH, Choi YK, Shin KI. The effect of clonidine pretreatment on cardiovascular response and seizure duration according to electroconvulsive therapy. Korean J Anesthesiol 2000;38:243-250. https://doi.org/10.4097/kjae.2000.38.2.243
  142. Elliott RL. Case report of a potential interaction between clonidine and electroconvulsive therapy. Am J Psychiatry 1983;140:1237-1238. https://doi.org/10.1176/ajp.140.9.1237
  143. Fu W, Stool LA, White PF, Husain MM. Is oral clonidine effective in modifying the acute hemodynamic response during electroconvulsive therapy? Anesth Analg 1998;86:1127-1130. https://doi.org/10.1213/00000539-199805000-00042
  144. Waite J, Easton A. The ECT Handbook: the third report of the royal college of psychiatrists' special committee of ECT. 2nd ed. London: RCPsych Publications;2005.
  145. Fink M. The ECT handbook : the second Report of the Royal College of Psychiatrists' Special Committee on ECT. London: Royal College of Psychiatrists 1995;12:127-132.
  146. Saito S, Kadoi Y, Nihishara F, Aso C, Goto F. End-tidal carbon dioxide monitoring stabilized hemodynamic changes during ECT. J ECT 2003;19:26-30. https://doi.org/10.1097/00124509-200303000-00006
  147. Tecoult E, Nathan N. Morbidity in electroconvulsive therapy. Eur J Anaesthesiol 2001;18:511-518. https://doi.org/10.1097/00003643-200108000-00005
  148. Heinzer R, Vat S, Marques-Vidal P, Marti-Soler H, Andries D, Tobback N, et al. Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. Lancet Respir Med 2015;3: 310-318. https://doi.org/10.1016/S2213-2600(15)00043-0
  149. Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 2013;177:1006-1014. https://doi.org/10.1093/aje/kws342
  150. Peppard PE, Young T, Palta M, Dempsey J, Skatrud J. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA 2000;284:3015-3021. https://doi.org/10.1001/jama.284.23.3015
  151. Babb TG, Wyrick BL, DeLorey DS, Chase PJ, Feng MY. Fat distribution and end-expiratory lung volume in lean and obese men and women. Chest 2008;134:704-711. https://doi.org/10.1378/chest.07-1728
  152. Rowley JA, Permutt S, Willey S, Smith PL, Schwartz AR. Effect of tracheal and tongue displacement on upper airway airflow dynamics. J Appl Physiol (1985) 1996;80:2171-2178. https://doi.org/10.1152/jappl.1996.80.6.2171
  153. Trakada G, Velentza L, Konsta A, Pataka A, Zarogoulidis P, Dikeos D. Complications of anesthesia during electroconvulsive therapy due to undiagnosed obstructive sleep apnea: a case-study. Respir Med Case Rep 2017;20:145-149.
  154. Stubbs B, Vancampfort D, Veronese N, Solmi M, Gaughran F, Manu P, et al. The prevalence and predictors of obstructive sleep apnea in major depressive disorder, bipolar disorder and schizophrenia: a systematic review and meta-analysis. J Affect Disord 2016;197:259-267. https://doi.org/10.1016/j.jad.2016.02.060
  155. Kikuchi A, Yasui-Furukori N, Fujii A, Katagai H, Kaneko S. Identification of predictors of post-ictal delirium after electroconvulsive therapy. Psychiatry Clin Neurosci 2009;63:180-185. https://doi.org/10.1111/j.1440-1819.2009.01930.x
  156. Mankad MV, Beyer JL, Weiner RD, Krystal AD. Clinical manual of electroconvulsive therapy. Washington, DC: American Psychiatric Publishing;2010.
  157. Cristancho MA, Alici Y, Augoustides JG, O'Reardon JP. Uncommon but serious complications associated with electroconvulsive therapy: recognition and management for the clinician. Curr Psychiatry Rep 2008;10:474-480. https://doi.org/10.1007/s11920-008-0076-4
  158. Augoustides JG, Greenblatt E, Abbas MA, O'Reardon JP, Datto CJ. Clinical approach to agitation after electroconvulsive therapy: a case report and literature review. J ECT 2002;18:213-217. https://doi.org/10.1097/00124509-200212000-00009
  159. Small JG, Milstein V. Lithium interactions: lithium and electroconvulsive therapy. J Clin Psychopharmacol 1990;10:346-350.
  160. Prudic J. Strategies to minimize cognitive side effects with ECT: aspects of ECT technique. J ECT 2008;24:46-51. https://doi.org/10.1097/YCT.0b013e31815ef238
  161. Reti IM, Krishnan A, Podlisky A, Sharp A, Walker M, Neufeld KJ, et al. Predictors of electroconvulsive therapy postictal delirium. Psychosomatics 2014;55:272-279. https://doi.org/10.1016/j.psym.2013.03.004
  162. Tzabazis A, Schmitt HJ, Ihmsen H, Schmidtlein M, Zimmermann R, Wielopolski J, et al. Postictal agitation after electroconvulsive therapy: incidence, severity, and propofol as a treatment option. J ECT 2013;29:189-195. https://doi.org/10.1097/YCT.0b013e3182887b5b